Revision history of "Dahlgaarddall2509"

Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • curprev 23:34, 21 November 2024Dahlgaarddall2509 talk contribs 6,707 bytes +6,707 Created page with "n-based neoadjuvant anti-HER2 therapy may be applied as an optimal treatment duration for screening high-risk HER2-positive breast cancer patients for escalation treatment. Fu..."